Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
139,295,316
-
Total 13F shares
-
11,679,733
-
Share change
-
+16,932
-
Total reported value
-
$35,039,000
-
Price per share
-
$3.00
-
Number of holders
-
10
-
Value change
-
+$50,902
-
Number of buys
-
4
-
Number of sells
-
2
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) as of Q2 2019
As of 30 Jun 2019,
Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,679,733 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Park West Asset Management LLC, Telemetry Investments, L.L.C., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, BlackRock Inc., MORGAN STANLEY, Winslow, Evans & Crocker, Inc., and ROYAL BANK OF CANADA.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.